Clinical Trials Browser

Interventional × saracatinib × Thoracic × Clear all

NCT00638937 2018-08-29

AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy

Phase 2 Completed

37 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung

NCT00528645 2017-12-07

AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer

Phase 2 Completed

23 enrolled 7 charts

Pleural Effusion, Malignant, Small Cell Lung Carcinoma

NCT00718809 2015-06-10

Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

Phase 2 Terminated

21 enrolled 13 charts

Thymoma

NCT00475956 2010-04-15

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

Phase 1 Completed

BreastGastrointestinalGynecologicPlasma cellThoracic

Breast Neoplasms, Choriocarcinoma, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT01000896 2010-02-04

Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel

Phase 1 Withdrawn

GynecologicThoracic

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Neoplasms